Yosef Landesman

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 19 papers. Top paper: “Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study”.

Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4929

N/A

0.953DataRank · unranked

25 citations

Husain Yar Khan, Yiwei Li, Mahmoud Chaker, Irfana Muqbil, Amro Aboukameel +18 more

XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma

Oncotarget(2016)10.18632/oncotarget.12969

N/A

0.680DataRank · unranked

92 citations

Trinayan Kashyap, Jana L. Dawson, Juan Gomez, Alexis A. Bauer, Steven Grant +6 more

A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2225

N/A

0.644DataRank · unranked

72 citations

Patrick Y. Wen, Martin J. van den Bent, Scott R. Plotkin, Annemiek Walenkamp, Adam L. Green +13 more

XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkB

Translational Oncology(2021)10.1016/j.tranon.2021.101114

N/A

0.489DataRank · unranked

25 citations

Marcus Luxemburg, Yosef Landesman, Bruce Pawel, Katherine J. Johnson, Stephen R. Master +5 more

Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects

Blood Advances(2023)10.1182/bloodadvances.2021006638

N/A

0.416DataRank · unranked

15 citations

Jing Fu, Christopher J. Walker, Jun Yang, Divaya Bhutani, Rajshekhar Chakraborty +5 more

Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer Cells

International Journal of Molecular Sciences(2021)10.3390/ijms22136676

N/A

0.385DataRank · unranked

12 citations

Yiwei Li, Husain Yar Khan, Irfana Muqbil, Amro Aboukameel, Rachel Sexton +6 more

SINE compounds activate exportin-1 degradation via an allosteric mechanism

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.10.07.617049

N/A

0.241DataRank · unranked

4 citations

Ho Yee Joyce Fung, Bert Kwanten, Tolga Çağatay, Ashley B. Niesman, Maarten Jacquemyn +12 more

Synthetic lethal targeting of TET2‐mutant haematopoietic stem and progenitor cells by XPO1 inhibitors

British Journal of Haematology(2023)10.1111/bjh.18667

N/A

0DataRank · unranked

7 citations

Nicole Prutsch, Shuning He, Mark W. Zimmerman, Yosef Landesman, A. Thomas Look +1 more

Data from Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study

(2023)10.1158/1078-0432.c.6530103

N/A

0DataRank · unranked

0 citations

Husain Yar Khan, Yiwei Li, Mahmoud Chaker, Irfana Muqbil, Amro Aboukameel +18 more

Data from Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study

(2023)10.1158/1078-0432.c.6530103.v1

N/A

0DataRank · unranked

0 citations

Husain Yar Khan, Yiwei Li, Mahmoud Chaker, Irfana Muqbil, Amro Aboukameel +18 more

Data from Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models

(2023)10.1158/1535-7163.c.6543538

N/A

0DataRank · unranked

0 citations

Cristian Rodriguez‐Aguayo, Shaolin Ma, Elaine Stur, Robiya Joseph, Emine Bayraktar +17 more

Data from Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers

(2023)10.1158/2767-9764.c.6550541

N/A

0DataRank · unranked

0 citations

Misako Nagasaka, Yiwei Li, Amro Aboukameel, Md. Hafiz Uddin, Rachel Sexton +13 more

Molecular profiling of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in cellular and LSL-Kras G12D/+; Trp53 fl/+; Pdx1-Cre (KPC) pancreatic cancer model

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.08.481108

N/A

0DataRank · unranked

0 citations

Amro Aboukameel, Yiwei Li, Husain Yar Khan, Rachel Sexton, Sahar F. Bannoura +11 more

Novel carfilzomib-based combinations as potential therapeutic strategies for liposarcomas

Cellular and Molecular Life Sciences(2020)10.1007/s00018-020-03620-w

N/A

0DataRank · unranked

13 citations

Aishvaryaa Prabhu, Pushkar Dakle, Elina Pathak, Vikas Madan, Deepika Kanojia +7 more

Small Molecule Inhibitors of Nuclear Export and the Amelioration of Lupus by Modulation of Plasma Cell Generation and Survival

Arthritis & Rheumatology(2022)10.1002/art.42128

N/A

0DataRank · unranked

2 citations

María de la Luz García-Hernández, Teresa Owen, Jennifer Barnard, Enrique Becerril‐Villanueva, Trinayan Kashyap +8 more

Inhibitor of the nuclear transport protein XPO1 enhances the anticancer efficacy of KRAS G12C inhibitors in preclinical models of KRAS G12C mutant cancers

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.26.477874

N/A

0DataRank · unranked

1 citations

Misako Nagasaka, Yiwei Li, Amro Aboukameel, Md. Hafiz Uddin, Rachel Sexton +13 more

Synthetic lethal targeting of TET2 -mutant hematopoietic stem and progenitor cells by XPO1 inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.12.511957

N/A

0DataRank · unranked

1 citations

Nicole Prutsch, Shuning He, Mark W. Zimmerman, Yosef Landesman, A. Thomas Look +1 more

Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignancies

Blood Advances(2020)10.1182/bloodadvances.2019000359

N/A

0DataRank · unranked

70 citations

Sharon Friedlander, Maria P. Arrate, Hua Chang, Agnieszka E. Gorska, Londa Fuller +13 more

Molecular analysis of XPO1 inhibitor and gemcitabine–nab‐paclitaxel combination in KPC pancreatic cancer mouse model

Clinical and Translational Medicine(2023)10.1002/ctm2.1513

N/A

0DataRank · unranked

17 citations

Mohammad Najeeb Al‐Hallak, Husain Yar Khan, Amro Aboukameel, Yiwei Li, Sahar F. Bannoura +14 more